Cevostamab demonstrated a 38.8% overall response rate in relapsed/refractory multiple myeloma, with a median response duration of 12.3 months. BCMA-naive patients showed a higher overall response rate ...
Sourcing Journal on MSN
Will Mexico’s Customs Reforms Give It a Leg Up in Pending USMCA Negotiations?
Mexico has taken a different tack from Canada when it comes to preserving and protecting its trade relationship with the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback